Sort
10,766 grants matching “checkpoint inhibitor”
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
$285,605Evanthia Theodosiou Roussos Torres · University Of Southern California · P20 · FY2024 · CA
Roles of DNA Ligase 1 in Mammalian DNA Metabolism
$285,020Alan E Tomkinson · University Of Maryland Baltimore · R01 · FY2009 · GM
Regulation of retrotransposition in S.cerevisiae
$284,866M Joan Curcio · Wadsworth Center · R01 · FY2007 · GM
Project 1
$284,803Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2022 · CA
PDX tumor-TME acquired resistance
$284,529Jack Roth · University Of California, San Francisco · U54 · FY2025 · CA
Mechanisms of Telomere Function
$284,364New York University School Of Medicine · R01 · FY2002 · CA
Bacterial delivery of pro-apoptotic proteins in advanced hepatocellular carcinoma.
$284,249Nele Van Dessel · Ernest Pharmaceuticals, Llc · R43 · FY2020 · CA
BUB1 in Chromosomal Instability and Tumorigenesis
$284,246Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2014 · CA
Project 3: HHLA2 as a THerapeutic Target in RCC
$284,060David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2021 · CA
DNA damage signaling in oxygen toxicity in lung cells
$284,000University Of Arkansas Med Scis Ltl Rock · R01 · FY2005 · HL
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
$283,860Christine Elizabeth Canman · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
$283,860Christine Elizabeth Canman · University Of Michigan At Ann Arbor · R01 · FY2008 · CA
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents
$283,860Christine Elizabeth Canman · University Of Michigan At Ann Arbor · R01 · FY2010 · CA
Signaling Complexes and the 14-3-3 Protein in Candida
$283,804Joy E Sturtevant · Lsu Health Sciences Center · R01 · FY2007 · AI
PDX tumor-TME acquired resistance
$283,621Jack Roth · University Of California, San Francisco · U54 · FY2023 · CA
Project 2
$283,399Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2021 · CA
Project 2
$283,281Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2022 · CA
Project 3
$283,170Michelle Krogsgaard · New York University School Of Medicine · P50 · FY2022 · CA
Intestinal Cell Growth Control: Role of Tyrosine Kinases
$282,823Christine Ann Cartwright · Stanford University · R01 · FY2010 · DK
Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression
$282,693Mary Kearney · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Project 3: Targeting Vulnerabilities in the Fibrotic Extracellular Matrix (ECM) of Lung Cancers
$282,687John D Minna · Ut Southwestern Medical Center · P50 · FY2023 · CA
Project 3: Targeting Vulnerabilities in the Fibrotic Extracellular Matrix (ECM) of Lung Cancers
$282,686John D Minna · Ut Southwestern Medical Center · P50 · FY2022 · CA
Function of the ATR-ATRIP complex
$282,600David K Cortez · Vanderbilt University · R01 · FY2016 · CA
Function of the ATR-ATRIP complex
$282,600David K Cortez · Vanderbilt University · R01 · FY2017 · CA
Function of the ATR-ATRIP complex
$282,600David K Cortez · Vanderbilt University · R01 · FY2015 · CA